This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Savid Therapeutics Inc., The University of Tokyo. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
1 out of 1,358 
Years Active: 2024
Title: Takefumi Yamashita: Innovator in Photoimmunotherapy
Introduction
Takefumi Yamashita is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of photoimmunotherapy through his innovative research and patents. His work focuses on the development of conjugates that enhance therapeutic applications.
Latest Patents
Yamashita holds a patent for a conjugate of a biotin-modified dimer and a phthalocyanine dye. This invention aims to provide a conjugate that is utilized in photoimmunotherapy. The compound is represented by a specific formula, which includes a salt thereof. This advancement is crucial for improving treatment methods in medical applications.
Career Highlights
Throughout his career, Takefumi Yamashita has been associated with prestigious institutions. He has worked at the University of Tokyo, where he contributed to various research projects. Additionally, he has been involved with Savid Therapeutics Inc., furthering his impact in the field of biotechnology.
Collaborations
Yamashita has collaborated with notable colleagues, including Motomu Kanai and Kenzo Yamatsugu. These partnerships have facilitated the exchange of ideas and advancements in their respective research areas.
Conclusion
Takefumi Yamashita's contributions to photoimmunotherapy through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile